454 related articles for article (PubMed ID: 34878902)
1. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
[TBL] [Abstract][Full Text] [Related]
2. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients.
Xiang H; Zhao Y; Li X; Liu P; Wang L; Wang M; Tian L; Sun HX; Zhang W; Xu Z; Ye B; Yuan X; Wang P; Zhang N; Gong Y; Bian C; Wang Z; Yu L; Yan J; Meng F; Bai C; Wang X; Liu X; Gao K; Wu L; Liu L; Gu Y; Bi Y; Shi Y; Zhang S; Zhu C; Xu X; Wu G; Gao GF; Yang N; Liu WJ; Yang P
Hum Immunol; 2022 Feb; 83(2):119-129. PubMed ID: 34785098
[TBL] [Abstract][Full Text] [Related]
3. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.
Nielsen SCA; Yang F; Jackson KJL; Hoh RA; Röltgen K; Jean GH; Stevens BA; Lee JY; Rustagi A; Rogers AJ; Powell AE; Hunter M; Najeeb J; Otrelo-Cardoso AR; Yost KE; Daniel B; Nadeau KC; Chang HY; Satpathy AT; Jardetzky TS; Kim PS; Wang TT; Pinsky BA; Blish CA; Boyd SD
Cell Host Microbe; 2020 Oct; 28(4):516-525.e5. PubMed ID: 32941787
[TBL] [Abstract][Full Text] [Related]
4. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing.
Jin X; Zhou W; Luo M; Wang P; Xu Z; Ma K; Cao H; Xu C; Huang Y; Cheng R; Xiao L; Lin X; Pang F; Li Y; Nie H; Jiang Q
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34015809
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19.
Montague Z; Lv H; Otwinowski J; DeWitt WS; Isacchini G; Yip GK; Ng WW; Tsang OT; Yuan M; Liu H; Wilson IA; Peiris JSM; Wu NC; Nourmohammad A; Mok CKP
Cell Rep; 2021 May; 35(8):109173. PubMed ID: 33991510
[TBL] [Abstract][Full Text] [Related]
6. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.
Yan Q; He P; Huang X; Luo K; Zhang Y; Yi H; Wang Q; Li F; Hou R; Fan X; Li P; Liu X; Liang H; Deng Y; Chen Z; Chen Y; Mo X; Feng L; Xiong X; Li S; Han J; Qu L; Niu X; Chen L
Emerg Microbes Infect; 2021 Dec; 10(1):1097-1111. PubMed ID: 33944697
[TBL] [Abstract][Full Text] [Related]
7. Evolution of antibody immunity to SARS-CoV-2.
Gaebler C; Wang Z; Lorenzi JCC; Muecksch F; Finkin S; Tokuyama M; Cho A; Jankovic M; Schaefer-Babajew D; Oliveira TY; Cipolla M; Viant C; Barnes CO; Bram Y; Breton G; Hägglöf T; Mendoza P; Hurley A; Turroja M; Gordon K; Millard KG; Ramos V; Schmidt F; Weisblum Y; Jha D; Tankelevich M; Martinez-Delgado G; Yee J; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Robbiani DF; Zhao Z; Gazumyan A; Schwartz RE; Hatziioannou T; Bjorkman PJ; Mehandru S; Bieniasz PD; Caskey M; Nussenzweig MC
Nature; 2021 Mar; 591(7851):639-644. PubMed ID: 33461210
[TBL] [Abstract][Full Text] [Related]
8. Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents.
Yan Q; Zhang Y; Hou R; Pan W; Liang H; Gao X; Deng W; Huang X; Qu L; Tang C; He P; Liu B; Wang Q; Zhao X; Lin Z; Chen Z; Li P; Han J; Xiong X; Zhao J; Li S; Niu X; Chen L
Emerg Microbes Infect; 2024 Dec; 13(1):2290841. PubMed ID: 38044868
[TBL] [Abstract][Full Text] [Related]
9. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
Galson JD; Schaetzle S; Bashford-Rogers RJM; Raybould MIJ; Kovaltsuk A; Kilpatrick GJ; Minter R; Finch DK; Dias J; James LK; Thomas G; Lee WJ; Betley J; Cavlan O; Leech A; Deane CM; Seoane J; Caldas C; Pennington DJ; Pfeffer P; Osbourn J
Front Immunol; 2020; 11():605170. PubMed ID: 33384691
[TBL] [Abstract][Full Text] [Related]
10. Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
Mor M; Werbner M; Alter J; Safra M; Chomsky E; Lee JC; Hada-Neeman S; Polonsky K; Nowell CJ; Clark AE; Roitburd-Berman A; Ben-Shalom N; Navon M; Rafael D; Sharim H; Kiner E; Griffis ER; Gershoni JM; Kobiler O; Leibel SL; Zimhony O; Carlin AF; Yaari G; Dessau M; Gal-Tanamy M; Hagin D; Croker BA; Freund NT
PLoS Pathog; 2021 Feb; 17(2):e1009165. PubMed ID: 33571304
[TBL] [Abstract][Full Text] [Related]
11. IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity.
de Mattos Barbosa MG; Liu H; Huynh D; Shelley G; Keller ET; Emmer BT; Sherman E; Ginsburg D; Kennedy AA; Tai AW; Wobus C; Mirabeli C; Lanigan TM; Samaniego M; Meng W; Rosenfeld AM; Prak ETL; Platt JL; Cascalho M
JCI Insight; 2021 May; 6(9):. PubMed ID: 33769311
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
13. Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection.
Arons E; Henry K; Haas C; Gould M; Tsintolas J; Mauter J; Zhou H; Burbelo PD; Cohen JI; Kreitman RJ
J Med Virol; 2023 Oct; 95(10):e29179. PubMed ID: 37877800
[TBL] [Abstract][Full Text] [Related]
14. B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination.
Kotagiri P; Mescia F; Rae WM; Bergamaschi L; Tuong ZK; Turner L; Hunter K; Gerber PP; Hosmillo M; ; Hess C; Clatworthy MR; Goodfellow IG; Matheson NJ; McKinney EF; Wills MR; Gupta RK; Bradley JR; Bashford-Rogers RJM; Lyons PA; Smith KGC
Cell Rep; 2022 Feb; 38(7):110393. PubMed ID: 35143756
[TBL] [Abstract][Full Text] [Related]
15. Stereotypic neutralizing V
Kim SI; Noh J; Kim S; Choi Y; Yoo DK; Lee Y; Lee H; Jung J; Kang CK; Song KH; Choe PG; Kim HB; Kim ES; Kim NJ; Seong MW; Park WB; Oh MD; Kwon S; Chung J
Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33397677
[TBL] [Abstract][Full Text] [Related]
16. Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2.
Xie J; Ding C; He J; Zhang Y; Ni S; Zhang X; Chen Q; Wang J; Huang L; He H; Li W; Ma H; Jin T; Zhang S; Gao Y
Front Immunol; 2021; 12():715464. PubMed ID: 34539645
[TBL] [Abstract][Full Text] [Related]
17. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
Front Immunol; 2021; 12():793191. PubMed ID: 34975897
[TBL] [Abstract][Full Text] [Related]
18. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
Chen JS; Chow RD; Song E; Mao T; Israelow B; Kamath K; Bozekowski J; Haynes WA; Filler RB; Menasche BL; Wei J; Alfajaro MM; Song W; Peng L; Carter L; Weinstein JS; Gowthaman U; Chen S; Craft J; Shon JC; Iwasaki A; Wilen CB; Eisenbarth SC
Sci Immunol; 2022 Feb; 7(68):eabl5652. PubMed ID: 34914544
[TBL] [Abstract][Full Text] [Related]
19. Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
Sakharkar M; Rappazzo CG; Wieland-Alter WF; Hsieh CL; Wrapp D; Esterman ES; Kaku CI; Wec AZ; Geoghegan JC; McLellan JS; Connor RI; Wright PF; Walker LM
Sci Immunol; 2021 Feb; 6(56):. PubMed ID: 33622975
[TBL] [Abstract][Full Text] [Related]
20. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
Yao L; Wang GL; Shen Y; Wang ZY; Zhan BD; Duan LJ; Lu B; Shi C; Gao YM; Peng HH; Wang GQ; Wang DM; Jiang MD; Cao GP; Ma MJ
J Infect Dis; 2021 Aug; 224(4):586-594. PubMed ID: 33978754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
